Journal of the Royal Society of Medicine
The most recent articles from:
J R Soc Med
-
Biography Historical Article
Pierre-Charles-Alexandre Louis and the evaluation of bloodletting.
-
Review Meta Analysis
Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis.
To examine whether the increased risk of cardiovascular events with rofecoxib represents a class effect of cyclooxygenase-2 (COX-2) specific inhibitors. ⋯ The available data indicate an increased risk of myocardial infarction with celecoxib therapy, consistent with a class effect for COX-2 specific inhibitors.